Cymat Technologies Stock Today
| CYMHF Stock | USD 0.14 0.02 12.50% |
PerformanceOK
| Odds Of DistressLow
|
Cymat Technologies is trading at 0.14 as of the 19th of July 2025. This is a 12.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.14. Cymat Technologies has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States. The company has 59.09 M outstanding shares. More on Cymat Technologies
Moving together with Cymat OTC Stock
Moving against Cymat OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cymat OTC Stock Highlights
| Business Concentration | Materials, Metals & Mining, Metal Fabrication, Industrials (View all Sectors) |
Cymat Technologies [CYMHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cymat Technologies's market, we take the total number of its shares issued and multiply it by Cymat Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cymat Technologies classifies itself under Metals & Mining sector and is part of Materials industry. The entity has 59.09 M outstanding shares.
Cymat Technologies has accumulated about 2.21 M in cash with (4.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Cymat Technologies Probability Of Bankruptcy
Ownership AllocationCymat Technologies holds a total of 59.09 Million outstanding shares. Cymat Technologies shows 6.28 percent of its outstanding shares held by insiders and 2.38 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cymat Ownership Details
Cymat Technologies Risk Profiles
| Mean Deviation | 4.63 | |||
| Semi Deviation | 5.44 | |||
| Standard Deviation | 10.4 | |||
| Variance | 108.18 |
Cymat Stock Against Markets
Picking the right benchmark for Cymat Technologies otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cymat Technologies otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cymat Technologies is critical whether you are bullish or bearish towards Cymat Technologies at a given time. Please also check how Cymat Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cymat Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Cymat Technologies Corporate Management
Elected by the shareholders, the Cymat Technologies' board of directors comprises two types of representatives: Cymat Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cymat. The board's role is to monitor Cymat Technologies' management team and ensure that shareholders' interests are well served. Cymat Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cymat Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jim Johnson | VP of Operations | Profile | |
| Darryl Kleebaum | Chief Officer | Profile | |
| Mario DeAngelis | Chief Officer | Profile | |
| Vince Benincasa | Chief Officer | Profile | |
| David Henry | Head Devel | Profile | |
| P MBA | Ex CEO | Profile |
Other Information on Investing in Cymat OTC Stock
Cymat Technologies financial ratios help investors to determine whether Cymat OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cymat with respect to the benefits of owning Cymat Technologies security.